Tuesday, May 10, 2022

Covaxin Maker Gets $19 Million For Development Of 'Variant Proof' Vaccine

CEPI on Tuesday said it will provide up to USD 19.3 million (about Rs 149 crore) to Bharat Biotech International, the University of Sydney, and Switzerland-based ExcellGene SA for the development of a...

from NDTV News - Special https://ift.tt/HAad5FK
at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Viral Video Shows 3,000 Engineers Queuing Up For Job Interview In Pune

In a viral video, over 3,000 engineers were seen queuing outside a Pune-based company for a recent walk-in drive targeting junior developer ...